[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341167-105":59,"doc-detail-341167-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-nogo-b-reduces-the-progression-of-pancreatic-cancer-by-regulation-nf-kbglut1-and-srebp1-pathways-summary-and-introduction","Inhibition of Nogo-B reduces the progression of pancreatic cancer by regulation - NF-kB/GLUT1 and SREBP1 pathways - Summary and Introduction","","Pancreatic cancer (PC) is a lethal malignancy associated with metabolic dysregulation, and the role of Nogo-B in PC had been unclear. In vitro results show Nogo-B knockout or knockdown markedly decreases cell viability and migration, while Nogo-B overexpression enhances these behaviors. In vivo, global Nogo deficiency reduces orthotopic tumor growth and metastasis. Glucose stimulation links to increased Nogo-B and NF-kB signaling, and NF-kB regulates GLUT1 and SREBP1 as downstream targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-nogo-b-reduces-the-progression-of-pancreatic-cancer-by-regulation-nf-kbglut1-and-srebp1-pathways-summary-and-introduction/341167/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-nogo-b-reduces-the-progression-of-pancreatic-cancer-by-regulation-nf-kbglut1-and-srebp1-pathways-summary-and-introduction/341167.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does Nogo-B affect pancreatic cancer cell behavior in vitro?","Question",{"text":112,"@type":113},"Nogo-B knockout or knockdown largely reduces cell viability and migration, whereas Nogo-B overexpression enhances them.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence supports the role of Nogo-B in vivo?",{"text":117,"@type":113},"Global Nogo knockout mice show reduced orthotopic tumor growth and metastasis.",{"name":119,"@type":110,"acceptedAnswer":120},"How are NF-kB, GLUT1, and SREBP1 connected to Nogo-B signaling?",{"text":121,"@type":113},"Glucose-related proliferation correlates with elevated Nogo-B and NF-kB, while Nogo-B deficiency reduces NF-kB, GLUT1, and SREBP1 expression; GLUT1 and SREBP1 are downstream targets of NF-kB.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341167,1790193527,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","iScience  \nll  \nOPEN ACCESS  \nArticle  \nInhibition of Nogo-B reduces the progression of pancreatic cancer by regulation NF-kB/GLUT1 and SREBP1 pathways  \nTianxiang Wang, Min Zhang, Xinyu Gong, ..., Lingling Wei, Yuanli Chen, Xiaoxiao Yang  \n[linglingwei@hfut.edu.cn](linglingwei@hfut.edu.cn) (L.W.)  \n[chenyuanli@hfut.edu.cn](chenyuanli@hfut.edu.cn) (Y.C.)  \n[yangxiaoxiao@hfut.edu.cn](yangxiaoxiao@hfut.edu.cn) (X.Y.)  \nHighlights  \nInhibition of Nogo-B reduces PC progress  \nNF-kB expression is involved in Nogo-Bmediated PC development  \nGLUT1 and SREBP1 are downstream targets of NFkB  \nNogo-B deﬁciency reduced PC via inhibiting NF-kB/GLUT1 and SREBP1 pathways  \nWang et al., iScience 27, 109741  \nMay 17, 2024 ª 2024 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/](https://doi.org/10.1016/)[ ](https://doi.org/10.1016/)[j.isci.2024.109741](j.isci.2024.109741)  \niScience  \nll  \nOPEN ACCESS  \nArticle  \nInhibition of Nogo-B reduces the progression of pancreatic cancer by regulation  \nNF-kB/GLUT1 and SREBP1 pathways  \nTianxiang Wang, 1,7 Min Zhang, 1,7 Xinyu Gong, 1 Wanjing Chen,2 Ying Peng, 1 Chenzhong Liao, 1 Hongmei Xu, 1 Qingshan Li,1 Guodong Shen,3 Huirong Ren,3 Yaxin Zhu,4 Baotong Zhang,5 Jiali Mao,6 Lingling Wei, 1,* Yuanli Chen, 1,* and Xiaoxiao Yang 1,8,*  \nSUMMARY  \nPancreatic cancer (PC) is a lethal disease and associated with metabolism dysregulation. Nogo-B is related to multiple metabolic related diseases and types of cancers. However, the role of Nogo-B in PC remains unknown. In vitro, we showed that cell viability and migration was largely reduced in Nogo-B knockout or knockdown cells, while enhanced by Nogo-B overexpression. Consistently, orthotopic tumor and metastasis was reduced in global Nogo knockout mice. Furthermore, we indicated that glucose enhanced cell proliferation was associated to the elevation expression of Nogo-B and nuclear factor kB (NF-kB). While, NF-kB, glucose transporter type 1 (GLUT1) and sterol regulatory element-binding protein 1 (SREBP1) expression was reduced in Nogo-B deﬁciency cells. In addition, we showed that GLUT1 and SREBP1 was downstream target of NF-kB. Therefore, we demonstrated that Nogo deﬁciency inhibited PC progression is regulated by the NF-kB/GLUT1 and SREBP1 pathways, and suggested that Nogo-B may bea target for PC therapy.  \nINTRODUCTION  \nPancreatic cancer (PC) is a global malignancy, and one of the most lethal diseases. More worryingly, PC is expected to overtake colorectal cancer and trail only lung cancer as the leading cause of cancer-related deaths by 2040 .1 Due to the vague symptoms and lack of early detection screening for PC, this disease is usually only discovered in its advanced stages, often after distant metastasis has occurred. As a result, the mortality rate of PC is extremely high. Chemotherapy and surgery are the main strategies for PC treatment. Unfortunately, only 15–20% patients are eligible to undergo the appropriate surgery. Despite complete resection, local or distant recurrence of PC is usually relapse within two years after surgery.2 In addition, the most recommended chemotherapy regimen for PC treatment is gemcitabine plus nab-paclitaxel and FOLFIRINOX, but acquired resistance is common.3,4 Therefore, the search for crucial regulatory molecules or mechanisms involved in PC development holds signiﬁcant clinical value and offers far-reaching societal beneﬁts.  \nThe progression of PC is complex, and metabolic rewiring plays a central role in this process. High glucose levels can contribute to the development and progression of PC.5 Increased glucose metabolism not only provides energy for tumor growth but also supports other biological processes necessary for cancer cell survival and proliferation. Additionally, elevated glucose levels can stimulate inﬂammation and induce insulin resistance, both of which are linked to an elevated risk of PC. Previous study indicated that high level of glucose transporter type 1 (GLUT1) in pancre","cbCaifUpEue8iqOV","https://ap.wps.com/l/cbCaifUpEue8iqOV","pdf",7630039,18,"English","# Summary\n# Introduction","[{\"question\":\"How does Nogo-B affect pancreatic cancer cell behavior in vitro?\",\"answer\":\"Nogo-B knockout or knockdown largely reduces cell viability and migration, whereas Nogo-B overexpression enhances them.\"},{\"question\":\"What evidence supports the role of Nogo-B in vivo?\",\"answer\":\"Global Nogo knockout mice show reduced orthotopic tumor growth and metastasis.\"},{\"question\":\"How are NF-kB, GLUT1, and SREBP1 connected to Nogo-B signaling?\",\"answer\":\"Glucose-related proliferation correlates with elevated Nogo-B and NF-kB, while Nogo-B deficiency reduces NF-kB, GLUT1, and SREBP1 expression; GLUT1 and SREBP1 are downstream targets of NF-kB.\"}]","Inhibition of Nogo-B reduces the progression of pancreatic cancer by regulation - NF-kB/GLUT1 and SREBP1 pathways - Summary and Introduction | PDF",1790040673,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0594c4ed797b4cd40b5320ac2eb27e5.webp",983,1276,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f31545474537ead22233e249b812bce.webp",982,1275,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd922c8f55e34e95df940f291d4dc741.webp",981,1273,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d1f386dfe25c6a29a7d64c73a52fb04.webp",980,1272]